Hologic sells Lifecodes to Immucor for $85M

Fri, 01/04/2013 - 4:50pm
Mass Device

Immucor agrees to acquire Hologic's Lifecodes transplant diagnostics business in a deal worth up to $95 million, marking the 1st publicly reported acquisition by Immucor since former Medtronic CEO William Hawkins took the corner office.

M&A illustration

In-vitro diagnostics maker Immucor (NSDQ:BLUD) signed a definitive agreement to acquire the Lifecodes transplant diagnostics business of Hologic (NSDQ:HOLX) in a deal worth up to $95 million.

Immucor paid $85 million in cash, with another $10 million to be paid out for certain financial milestones, according to a press release.

The Lifecodes business is a "worldwide leader in transplantation diagnostics," part of a $400 million global market that Immucor says is growing fast. Hologic acquired Lifecodes' technology in August 2012 when it acquired molecular diagnostics giant Gen-Probe (NSDQ:GPRO) for $4 billion.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.